BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36637709)

  • 21. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications.
    Meloni A; Martini N; Positano V; De Luca A; Pistoia L; Sbragi S; Spasiano A; Casini T; Bitti PP; Allò M; Sanna PMG; De Caterina R; Sinagra G; Pepe A
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):70. PubMed ID: 34120634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study.
    Pepe A; Pistoia L; Gamberini MR; Cuccia L; Peluso A; Messina G; Spasiano A; Allò M; Bisconte MG; Putti MC; Casini T; Dello Iacono N; Celli M; Vitucci A; Giuliano P; Peritore G; Renne S; Righi R; Positano V; De Sanctis V; Meloni A
    Diabetes Care; 2020 Nov; 43(11):2830-2839. PubMed ID: 32887708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta-thalassemia major: correlation with T2* cardiovascular magnetic resonance.
    Aypar E; Alehan D; Hazirolan T; Gümrük F
    Int J Cardiovasc Imaging; 2010 Apr; 26(4):413-21. PubMed ID: 20127175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of Myocardial Extracellular Volume Fraction with Cardiac MR Imaging in Thalassemia Major.
    Hanneman K; Nguyen ET; Thavendiranathan P; Ward R; Greiser A; Jolly MP; Butany J; Yang IY; Sussman MS; Wintersperger BJ
    Radiology; 2016 Jun; 279(3):720-30. PubMed ID: 26653680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Exercise Stress Echocardiography for Determination of Subclinical Cardiac Involvement in β-Thalassemia Major.
    Parsaee M; Pouraliakbar H; Azarkeivan A; Ghadrdoost B; Behjati M
    Hemoglobin; 2019 Jan; 43(1):34-37. PubMed ID: 31084365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction.
    Eitel I; Pöss J; Jobs A; Eitel C; de Waha S; Barkhausen J; Desch S; Thiele H
    J Cardiovasc Magn Reson; 2015 Jul; 17(1):62. PubMed ID: 26174798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients.
    Pattanakuhar S; Phrommintikul A; Tantiworawit A; Konginn S; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major.
    Fedai AB; Karakulak UN; Aladag E; Sayinalp N
    Cardiovasc Toxicol; 2024 Jan; 24(1):41-48. PubMed ID: 38108958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic evaluation of left atrial strain for predicting iron overload in pediatric patients with β-thalassemia with preserved ejection fraction.
    Luo SL; Deng Y; Lan WF; Yang YH; Dai P
    Int J Cardiovasc Imaging; 2023 May; 39(5):895-906. PubMed ID: 36607471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How early can myocardial iron overload occur in beta thalassemia major?
    Yang G; Liu R; Peng P; Long L; Zhang X; Yang W; Tan S; Pan H; Long X; He T; Anderson L; Lai Y
    PLoS One; 2014; 9(1):e85379. PubMed ID: 24465548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular systolic dyssynchrony index and endothelial dysfunction parameters as subclinical predictors of cardiovascular involvement in patients with beta-thalassemia major.
    Solmaz H; Cabuk AK; Altin Z; Albudak Ozcan E; Ozdogan O
    Echocardiography; 2021 Jun; 38(6):825-833. PubMed ID: 33945174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Cardiac Magnetic Resonance Feature Tracking of the Right Ventricle in Predicting Subclinical Dysfunction in Patients with Thalassemia Major.
    Das KM; Baskaki UMA; Pulinchani A; Ali HM; Almanssori TM; Gorkom KV; Das A; Dewedar H; Sharma S
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation between cardiac magnetic resonance T2* and left ventricular global longitudinal strain in people with β-thalassemia.
    Parsaee M; Akiash N; Azarkeivan A; Alizadeh Sani Z; Amin A; Pazoki M; Samiei N; Jalili MA; Adel MH; Rezaian N
    Echocardiography; 2018 Apr; 35(4):438-444. PubMed ID: 29399871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major.
    Meloni A; Pistoia L; Gamberini MR; Cuccia L; Lisi R; Cecinati V; Ricchi P; Gerardi C; Restaino G; Righi R; Positano V; Cademartiri F
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biventricular Reference Values by Body Surface Area, Age, and Gender in a Large Cohort of Well-Treated Thalassemia Major Patients Without Heart Damage Using a Multiparametric CMR Approach.
    Meloni A; Righi R; Missere M; Renne S; Schicchi N; Gamberini MR; Cuccia L; Lisi R; Spasiano A; Roberti MG; Zuccarelli A; Ait-Ali L; Festa P; Aquaro GD; Mangione M; Barra V; Positano V; Pepe A
    J Magn Reson Imaging; 2021 Jan; 53(1):61-70. PubMed ID: 32311193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
    Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
    J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How does iron deposition modify the myocardium? A feature-tracking cardiac magnetic resonance study.
    Asadian S; Rezaeian N; Hosseini L; Toloueitabar Y; Komasi MMH; Shayan L
    Int J Cardiovasc Imaging; 2021 Nov; 37(11):3269-3277. PubMed ID: 34105082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the Prognostic Value of MRI Left Ventricular Global Function Index (LVGFI) in Patients With End-Stage Renal Disease Under Maintenance Dialysis.
    Zhang TY; An DA; Fang Y; Zhou H; Yan H; Chen B; Lu R; Fang W; Wang Q; Che X; Xu Y; Huang J; Jin H; Shen J; Mou S; Wu LM
    J Magn Reson Imaging; 2024 Jun; 59(6):2275-2286. PubMed ID: 37668069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.